Literature DB >> 18724233

Limited efficacy and unacceptable toxicity of cyclophosphamide for the induction of mixed chimerism and renal allograft tolerance in cynomolgus monkeys.

Hiroshi Sogawa1, Svjetlan Boskovic, Ognjenka Nadazdin, Greg Abrahamian, Robert B Colvin, David H Sachs, A Benedict Cosimi, Tatsuo Kawai.   

Abstract

To induce mixed chimerism and renal allograft tolerance in cynomolgus monkeys, cyclophosphamide (CP) and total body irradiation (TBI) were compared as part of a nonmyeloablative conditioning regimen. CP induced dose-dependent neutropenia and lymphopenia, but hematopoietic recovery was more rapid than that observed in the TBI group. Absolute B cell counts after CP were significantly higher (P<0.01) than those in the TBI group. With CP, a total dose of 200 mg/kg with CD154 blockade regularly induced multilineage chimerism. Nevertheless, the recipients failed to achieve long-term survival because of rejection (3 of 5), posttransplantation B cell lymphoma (1 of 5), and toxicities of CP (1 of 5). As previously reported, 3 Gy of TBI with either splenectomy or CD154 blockade induced mixed chimerism and renal allograft tolerance, with significantly less morbidity and mortality than that produced by CP. Thus, TBI is more effective and less toxic than CP as part of a nonmyeloablative regimen for the induction of mixed chimerism and renal allograft tolerance in cynomolgus monkeys.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18724233      PMCID: PMC2786005          DOI: 10.1097/TP.0b013e3181821bac

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

1.  CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.

Authors:  S Nikiforow; K Bottomly; G Miller
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates.

Authors:  Tatsuo Kawai; Hiroshi Sogawa; Svetlan Boskovic; Gregory Abrahamian; Rex-Neal Smith; Siew-Lin Wee; David Andrews; Ognjenka Nadazdin; Ichiro Koyama; Megan Sykes; Henry J Winn; Robert B Colvin; David H Sachs; A Benedict Cosimi
Journal:  Am J Transplant       Date:  2004-09       Impact factor: 8.086

3.  Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys.

Authors:  M Kimikawa; D H Sachs; R B Colvin; A Bartholomew; T Kawai; A B Cosimi
Journal:  Transplantation       Date:  1997-09-15       Impact factor: 4.939

4.  Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody.

Authors:  A B Cosimi; F L Delmonico; J K Wright; S L Wee; F I Preffer; L K Jolliffe; R B Colvin
Journal:  Surgery       Date:  1990-08       Impact factor: 3.982

5.  Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease.

Authors:  Leo H Bühler; Thomas R Spitzer; Megan Sykes; David H Sachs; Francis L Delmonico; Nina Tolkoff-Rubin; Susan L Saidman; Robert Sackstein; Steven McAfee; Bimalangshu Dey; Christine Colby; A Benedict Cosimi
Journal:  Transplantation       Date:  2002-11-27       Impact factor: 4.939

6.  Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism.

Authors:  T R Spitzer; F Delmonico; N Tolkoff-Rubin; S McAfee; R Sackstein; S Saidman; C Colby; M Sykes; D H Sachs; A B Cosimi
Journal:  Transplantation       Date:  1999-08-27       Impact factor: 4.939

7.  Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance.

Authors:  T Kawai; A Poncelet; D H Sachs; S Mauiyyedi; S Boskovic; S L Wee; D S Ko; A Bartholomew; M Kimikawa; H Z Hong; G Abrahamian; R B Colvin; A B Cosimi
Journal:  Transplantation       Date:  1999-12-15       Impact factor: 4.939

8.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; A Benedict Cosimi; Thomas R Spitzer; Nina Tolkoff-Rubin; Manikkam Suthanthiran; Susan L Saidman; Juanita Shaffer; Frederic I Preffer; Ruchuang Ding; Vijay Sharma; Jay A Fishman; Bimalangshu Dey; Dicken S C Ko; Martin Hertl; Nelson B Goes; Waichi Wong; Winfred W Williams; Robert B Colvin; Megan Sykes; David H Sachs
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

9.  Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys.

Authors:  T Kawai; A B Cosimi; R B Colvin; J Powelson; J Eason; T Kozlowski; M Sykes; R Monroy; M Tanaka; D H Sachs
Journal:  Transplantation       Date:  1995-01-27       Impact factor: 4.939

10.  Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen.

Authors:  Y Sharabi; D H Sachs
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

View more
  4 in total

1.  Cyclophosphamide and fludarabine monophosphate dose optimization for the non-myeloablative condition in non-human primates to induce transient mixed chimerism via bone marrow transplantation.

Authors:  Yeongbeen Kwon; Kyo Won Lee; Hyojun Park; Jin Kyung Son; JongHyun Lee; Chan Woo Cho; Ghee Young Kwon; Jae Berm Park; Sung Joo Kim
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

2.  Expansion of CD45RA-FOXP3++ regulatory T cells is associated with immune tolerance in patients with combined kidney and bone marrow transplantation.

Authors:  Yeongbeen Kwon; Kyo Won Lee; You Min Kim; Hyojun Park; Min Kyung Jung; Young Joon Choi; Jin Kyung Son; JuHee Hong; Su-Hyung Park; Ghee Young Kwon; Heejin Yoo; Kyunga Kim; Sung Joo Kim; Jae Berm Park; Eui-Cheol Shin
Journal:  Clin Transl Immunology       Date:  2021-08-09

3.  Up-regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation.

Authors:  Takahiro Tomiyama; Takuya Yamamoto; Shokichi Takahama; Takeo Toshima; Shinji Itoh; Noboru Harada; Mototsugu Shimokawa; Daisuke Okuzaki; Masaki Mori; Tomoharu Yoshizumi
Journal:  Hepatol Commun       Date:  2022-07-27

4.  Pathogenicity of pandemic H1N1 influenza A virus in immunocompromised cynomolgus macaques.

Authors:  Van Loi Pham; Misako Nakayama; Yasushi Itoh; Hirohito Ishigaki; Mitsutaka Kitano; Masahiko Arikata; Hideaki Ishida; Naoko Kitagawa; Shintaro Shichinohe; Masatoshi Okamatsu; Yoshihiro Sakoda; Hideaki Tsuchiya; Shinichiro Nakamura; Hiroshi Kida; Kazumasa Ogasawara
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.